As of January 2025, Transgene has a market cap of $72.83M. This makes Transgene the world's 21360th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $122.60M | -14.60% |
2023 | $143.56M | -17.37% |
2022 | $173.74M | -34.72% |
2021 | $266.16M | 54.13% |
2020 | $172.69M | 6.32% |
2019 | $162.42M | -41.77% |
2018 | $278.91M | -3.53% |
2017 | $289.13M | 5.60% |
2016 | $273.81M | 4.28% |
2015 | $262.57M | -63.29% |
2014 | $715.17M | -20.27% |
2013 | $897.02M | 9.89% |
2012 | $816.31M | 3.77% |
2011 | $786.68M | -45.00% |
2010 | $1.43B | -32.64% |
2009 | $2.12B | 76.03% |
2008 | $1.21B | -18.84% |
2007 | $1.49B | 16.67% |
2006 | $1.27B | 80.00% |
2005 | $707.78M | 4.95% |
2004 | $674.42M | 4.22% |
2003 | $647.12M | 27.49% |
2002 | $507.58M | -29.30% |
2001 | $717.90M | -70.42% |
2000 | $2.43B | - |